NCT07638345 DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions
| NCT ID | NCT07638345 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Adhera Health, Inc. |
| Condition | Type 1 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 280 participants |
| Start Date | 2025-10-30 |
| Primary Completion | 2026-03-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 280 participants in total. It began in 2025-10-30 with a primary completion date of 2026-03-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective single-arm feasibility study evaluates the Adhera Caring Digital Program for Obesity (ACDP-O), a family-centered digital health intervention designed to support adolescents and young adults with overweight/obesity and chronic conditions, including type 1 diabetes (T1D) and asthma. The intervention combines personalized educational content, wearable-device monitoring, psychometric assessments, and explainable artificial intelligence (AI) to improve mental well-being, quality of life, and adherence to healthy lifestyle behaviors. A total of 280 families will participate in a 3-month intervention with remote monitoring and follow-up assessments.
Eligibility Criteria
Inclusion Criteria: * Adult caregiver (aged 18 years or older) of an adolescent or young adult aged 12 to 21 years diagnosed with Type 1 Diabetes (T1D) or asthma. * The caregiver is actively involved in the management of the adolescent's or young adult's condition. * The adolescent or young adult must meet one of the following criteria: * T1D and normal weight (BMI between the 10th and 85th percentile), or * T1D and overweight/obesity (BMI ≥85th percentile), or * Asthma and overweight/obesity (BMI ≥85th percentile). * Willingness to participate in the Adhera Caring Digital Program-Obesity (ACDP-O). * Access to a smartphone or internet-enabled device compatible with the study application. * Willingness to provide self-reported information regarding the adolescent's or young adult's health status, including disease-related and anthropometric measures. * For caregivers of participants with T1D, willingness to share continuous glucose monitoring (CGM) information. Exclusion Criteria: * Severe psychiatric or cognitive conditions that would interfere with participation in the digital intervention. * Current participation in another obesity- or chronic disease-related digital health intervention study. * Inability or unwillingness to comply with study procedures. * Refusal or inability to provide informed consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07638345 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Type 1 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07638345 currently recruiting?
Yes, NCT07638345 is actively recruiting participants. Contact the research team at luis@adherahealth.com for enrollment information.
Where is the NCT07638345 trial being conducted?
This trial is being conducted at Seville, Spain.
Who is sponsoring the NCT07638345 clinical trial?
NCT07638345 is sponsored by Adhera Health, Inc.. The trial plans to enroll 280 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.